Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report

Mrinal Gupta; Paul S Yamauchi; Martine Bagot; Jacek Szepietowski; Shibani Bhatia; Torello Lotti; Mohamad Goldust

doi:10.1002/ccr3.2971

Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report

Clin Case Rep. 2020 May 26;8(9):1647-1650. doi: 10.1002/ccr3.2971. eCollection 2020 Sep.

Authors

Mrinal Gupta¹, Paul S Yamauchi^{2

3}, Martine Bagot⁴, Jacek Szepietowski⁵, Shibani Bhatia⁶, Torello Lotti⁷, Mohamad Goldust^{8

9

10

11}

Affiliations

¹ Treatwell Skin Centre Jammu India.
² Dermatology Institute and Skin Care Center Santa Monica California USA.
³ Division of Dermatology David Geffen School of Medicine at University of California Los Angeles California USA.
⁴ AP-HP Dermatology Department Saint-Louis Hospital INSERM U976 Université Paris Diderot-Paris VII Sorbonne Paris Cité Paris France.
⁵ Department of Dermatology, Venereology and Allergology Wroclaw Medical University Wroclaw Poland.
⁶ Department of Dermatology, Venereology and Leprosy Kasturba medical college Manipal Manipal Academy of Higher Education Manipal India.
⁷ University of Studies Guglielmo Marconi Rome Italy.
⁸ Mazandaran University of Medical Sciences Sari Iran.
⁹ University of Rome G. Marconi Rome Italy.
¹⁰ Department of Dermatology University Medical Center Mainz Mainz Germany.
¹¹ Department of Dermatology University Hospital Basel Basel Switzerland.

Abstract

Recombinant interferon beta-1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.

Keywords: interferon beta‐1b; morphea; multiple sclerosis.

Publication types

Case Reports